Tag: FDA Warning

Testosterone replacement therapy and cardiovascular risk

Testosterone replacement therapy (TRT) has long been used for young men with organic hypogonadism, but its increasing use in older men with age-related testosterone decline has raised concerns about cardiovascular (CV) risk. Some studies suggest TRT may elevate the risk of cardiovascular disease (CVD), leading to FDA warnings, though no

Read More ยป